"Glucocorticoids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.
| Descriptor ID |
D005938
|
| MeSH Number(s) |
D06.472.040.543 D27.505.696.399.472.488
|
| Concept/Terms |
Glucocorticoid Effect- Glucocorticoid Effect
- Effect, Glucocorticoid
- Glucorticoid Effects
- Effects, Glucorticoid
|
Below are MeSH descriptors whose meaning is more general than "Glucocorticoids".
Below are MeSH descriptors whose meaning is more specific than "Glucocorticoids".
This graph shows the total number of publications written about "Glucocorticoids" by people in this website by year, and whether "Glucocorticoids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 3 | 3 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 4 | 5 |
| 2009 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 2 | 4 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 4 | 1 | 5 |
| 2016 | 1 | 2 | 3 |
| 2017 | 1 | 2 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 3 | 4 | 7 |
| 2020 | 3 | 1 | 4 |
| 2021 | 1 | 4 | 5 |
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucocorticoids" by people in Profiles.
-
The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema. Am J Ophthalmol. 2023 04; 248:16-23.
-
Glucocorticoids in Myositis: Initiation, Tapering, and Discontinuation. Curr Rheumatol Rep. 2022 Mar; 24(3):47-53.
-
Are Intraarticular Glucocorticoids Safe in Osteoarthritis? Arthritis Rheumatol. 2022 02; 74(2):181-183.
-
Suprachoroidal triamcinolone acetonide versus rescue therapies for the treatment of uveitic macular oedema: A post hoc analysis of PEACHTREE. Clin Exp Ophthalmol. 2022 01; 50(1):23-30.
-
Insulin management in hospitalized patients with diabetes mellitus on high-dose glucocorticoids: Management of steroid-exacerbated hyperglycemia. PLoS One. 2021; 16(9):e0256682.
-
Suprachoroidal CLS-TA with and without Systemic Corticosteroid and/or Steroid-Sparing Therapy: A Post-Hoc Analysis of the Phase 3 PEACHTREE Clinical Trial. Ocul Immunol Inflamm. 2023 Oct; 31(8):1579-1586.
-
Spermatic Cord Block Series as a Minimally Invasive Therapy for Chronic Scrotal Content Pain. J Urol. 2021 Sep; 206(3):725-732.
-
Efficacy of Office-Based Intralesional Steroid Injections in the Management of Subglottic Stenosis: A Systematic Review. Ear Nose Throat J. 2023 Jun; 102(6):372-378.
-
Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA). Br J Ophthalmol. 2022 08; 106(8):1139-1144.
-
Pain Management Best Practices from Multispecialty Organizations During the COVID-19 Pandemic and Public Health Crises. Pain Med. 2020 11 07; 21(7):1331-1346.